A61K 31/606
Having amino groups
Official title: having amino groups
A61K31/606 (Having amino groups) appears on 223 US grants and 415 published applications in this corpus.
Search patents in A61K- Granted patents
- 223
- Published applications
- 415
- Assignees
- 207
- Inventors
- 593
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 1 |
| 2002 | 3 | 5 |
| 2003 | 4 | 7 |
| 2004 | 4 | 2 |
| 2005 | 3 | 7 |
| 2006 | 2 | 12 |
| 2007 | 0 | 10 |
| 2008 | 4 | 6 |
| 2009 | 8 | 16 |
| 2010 | 6 | 21 |
| 2011 | 3 | 7 |
| 2012 | 11 | 14 |
| 2013 | 9 | 30 |
| 2014 | 11 | 22 |
| 2015 | 13 | 36 |
| 2016 | 10 | 21 |
| 2017 | 11 | 22 |
| 2018 | 16 | 28 |
| 2019 | 18 | 23 |
| 2020 | 20 | 22 |
| 2021 | 12 | 26 |
| 2022 | 11 | 26 |
| 2023 | 9 | 19 |
| 2024 | 7 | 12 |
| 2025 | 9 | 14 |
| 2026 | 6 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating hepatic encephalopathy4 Aug 2026US 12,697,326 B2Salix Pharmaceuticals, Inc.
- Polymeric carriers for delivery of therapeutic agents14 Jul 2026US 12,678,448 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods of monitoring inflammatory bowel diseases9 Jun 2026US 12,650,434 B2Icahn School of Medicine at Mount Sinai
- Nongranulated compressed tablets of mesalamine, and process of preparation thereof26 May 2026US 12,636,255 B2Atoz Pharmaceuticals Pvt Ltd
- Preparation method of salfaprodil freeze-dried powder injection, and product and use thereof17 Mar 2026US 12,576,091 B2Gnt Pharma Co., Ltd.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modulators1 Oct 2026US 2026/0294856 A1
- Methods and models for post-operative recurrence in crohn's disease9 Jul 2026US 2026/0193710 A1Cedars-Sinai Medical Center
- Translocator protein ligands and inflammatory diseases25 Jun 2026US 2026/0174761 A1Technion Research & Development Foundation Limited
- Pharmaceutical formulation for the treatment of inflammatory changes to the rectum26 Feb 2026US 2026/0053818 A1Dr. Falk Pharma GmbH
Most cited
By later US patents
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery164US 5,686,105 AThe Procter & Gamble Company · 1997
- Delivery of drugs to the lower GI tract147US 5,811,388 ACibus Pharmaceutical, Inc. · 1998
- Multi-particulate form of medicament, comprising at least two differently coated forms of pellet111US 6,897,205 B2Roehm GmbH · 2005
- Methods of treating diarrhea caused by small intestinal bacterial overgrowth81US 7,935,799 B2Cedars-Sinai Medical Center · 2011